MoneyWorks4Me

Orchid Pharma - Quaterly Results

17 May 2022 Evaluate
A decent increase of about 49.58% in the sales to Rs. 1802.34 millions was observed for the quarter ended March 2022. The sales figure stood at Rs. 1204.94 millions during the year-ago period.The Total Profit for the quarter ended March 2022 of Rs. 1.39 millions grew from Rs.-59.54 millionsOperating profit for the quarter ended March 2022 rose to 312.25 millions as compared to 262.54 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1802.34 1204.94 49.58 5569.74 4506.95 23.58 5569.74 4506.95 23.58
Other Income 17.47 25.36 -31.11 90.03 64.61 39.34 90.03 64.61 39.34
PBIDT 312.25 262.54 18.93 662.62 643.62 2.95 662.62 643.62 2.95
Interest 44.59 118.86 -62.49 320.12 513.36 -37.64 320.12 513.36 -37.64
PBDT 267.66 143.68 86.29 342.50 130.26 162.94 342.50 130.26 162.94
Depreciation 266.27 203.22 31.03 870.21 1088.99 -20.09 870.21 1088.99 -20.09
PBT 1.39 -59.54 -102.33 -527.71 -958.73 -44.96 -527.71 -958.73 -44.96
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1.39 -59.54 -102.33 -527.71 -958.73 -44.96 -527.71 -958.73 -44.96
Equity 408.16 408.16 0.00 408.16 408.16 0.00 408.16 408.16 0.00
PBIDTM(%) 17.32 21.79 -20.49 11.90 14.28 -16.69 11.90 14.28 -16.69
Peers
Company Name CMP
Sun Pharma. Inds. 1847.05
Dr. Reddys Labs. 1145.25
Cipla 1359.25
Lupin 2050.95
Zydus Lifesciences 1108.25
View more..